Publications

Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.

Authors: AN Holding, FM Giorgi, A Donnelly, AE Cullen, S Nagarajan, LA Selth, F Mark...

E-pub date: 14 Jun 2019

Journal name: Genome Biol

3D-printed moulds for image-guided surgical biopsies: an open source computational platform

Authors: M Crispin-Ortuzar, M Gehrung, S Ursprung, A Gill, A Warren, L Beer, F Galla...

E-pub date: 3 Jun 2019

Journal name:

IL-1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype.

Authors: KA Wiggins, AJ Parry, LD Cassidy, M Humphry, SJ Webster, JC Goodall, M Nari...

E-pub date: 1 Jun 2019

Journal name: Aging Cell

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

Authors: L De Mattos-Arruda, S-J Sammut, EM Ross, R Bashford-Rogers, E Greenstein, H...

E-pub date: 28 May 2019

Journal name: Cell Rep

Co-Registration of Optoacoustic Tomography and Magnetic Resonance Imaging Data from Murine Tumour Models

Authors: M Gehrung, M Tomaszewski, D McIntyre, J Disselhorst, S Bohndiek

E-pub date: 26 May 2019

Journal name:

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

Authors: S Lheureux, M Cabanero, MC Cristea, G Mantia-Smaldone, A Olawaiye, S Ellard...

E-pub date: 20 May 2019

Journal name: Journal of Clinical Oncology

Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

Authors: ML Goodman, GM Trinca, KR Walter, EK Papachristou, CS D'Santos, T Li, Q Liu...

E-pub date: 15 May 2019

Journal name: J Immunol

VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.

Authors: AN Holding, FM Giorgi, A Donnelly, AE Cullen, S Nagarajan, LA Selth, F Mark...

E-pub date: 13 May 2019

Journal name: Genome Biol

Filters

Research Groups

Core Facilities

Start date

End date

Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.

3D-printed moulds for image-guided surgical biopsies: an open source computational platform

IL-1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype.

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

Co-Registration of Optoacoustic Tomography and Magnetic Resonance Imaging Data from Murine Tumour Models

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.

3D-printed moulds for image-guided surgical biopsies: an open source computational platform

IL-1α cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype.

The Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer.

Co-Registration of Optoacoustic Tomography and Magnetic Resonance Imaging Data from Murine Tumour Models

A randomized double-blind placebo-controlled phase II trial comparing gemcitabine monotherapy to gemcitabine in combination with adavosertib in women with recurrent, platinum resistant epithelial ovarian cancer: A trial of the Princess Margaret, California, Chicago and Mayo Phase II Consortia.

Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.

VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.